AI assistant
Sending…
EXAGEN INC. — Director's Dealing 2025
Feb 25, 2025
33644_dirs_2025-02-25_75d5a4ca-9ee0-4047-b59b-3d5109c93e97.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2024-11-14
Reporting Person: ABALLI JOHN (Director, President and CEO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 625093 | Direct |
| Common Stock | 40401 | Indirect |
Footnotes
F1: On November 18, 2024, the reporting person filed a Form 4 which inadvertently reported that, following his purchase of 24,305 shares of common stock, he directly owned 689,799 shares of common stock. In fact, as reported in this amendment, the reporting person directly owned 625,093 shares of common stock and indirectly owned 40,401 shares of common stock.
More from EXAGEN INC.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 23
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11